Caricamento...
The Tumor Immune Contexture of Prostate Cancer
One in seven men in North America is expected to be diagnosed with prostate cancer (PCa) during their lifetime (1, 2). While a wide range of treatment options including surgery, radiation, androgen deprivation and chemotherapy have been in practice for the last few decades, there are limited treatme...
Salvato in:
| Pubblicato in: | Front Immunol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6447686/ https://ncbi.nlm.nih.gov/pubmed/30984182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.00603 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|